Literature DB >> 10974443

A comparison of ventilatory prostate movement in four treatment positions.

L A Dawson1, D W Litzenberg, K K Brock, M Sanda, M Sullivan, H M Sandler, J M Balter.   

Abstract

PURPOSE: To ensure target coverage during radiotherapy, all sources of geometric uncertainty in target position must be considered. Movement of the prostate due to breathing has not traditionally been considered in prostate radiotherapy. The purpose of this study is to report the influence of patient orientation and immobilization on prostate movement due to breathing. METHODS AND MATERIALS: Four patients had radiopaque markers implanted in the prostate. Fluoroscopy was performed in four different positions: prone in alpha cradle, prone with an aquaplast mold, supine on a flat table, and supine with a false table under the buttocks. Fluoroscopic movies were videotaped and digitized. Frames were analyzed using 2D-alignment software to determine the extent of movement of the prostate markers and the skeleton for each position during normal and deep breathing.
RESULTS: During normal breathing, maximal movement of the prostate markers was seen in the prone position (cranial-caudal [CC] range: 0.9-5.1 mm; anterior-posterior [AP] range: up to 3.5 mm). In the supine position, prostate movement during normal breathing was less than 1 mm in all directions. Deep breathing resulted in CC movements of 3.8-10.5 mm in the prone position (with and without an aquaplast mold). This range was reduced to 2.0-7.3 mm in the supine position and 0.5-2.1 mm with the use of the false table top. Deep breathing resulted in AP skeletal movements of 2.7-13.1 mm in the prone position, whereas AP skeletal movements in the supine position were negligible.
CONCLUSION: Ventilatory movement of the prostate is substantial in the prone position and is reduced in the supine position. The potential for breathing to influence prostate movement, and thus the dose delivered to the prostate and normal tissues, should be considered when positioning and planning patients for conformal irradiation.

Entities:  

Mesh:

Year:  2000        PMID: 10974443     DOI: 10.1016/s0360-3016(00)00751-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

Review 1.  Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.

Authors:  Alan Pollack; Alex Hanlon; Eric M Horwitz; Steven Feigenberg; Robert G Uzzo; Robert A Price
Journal:  World J Urol       Date:  2003-09-05       Impact factor: 4.226

2.  Comparison of dose decrement from intrafraction motion for prone and supine prostate radiotherapy.

Authors:  Jeffrey R Olsen; Parag J Parikh; Michael Watts; Camille E Noel; Kenneth W Baker; Lakshmi Santanam; Jeff M Michalski
Journal:  Radiother Oncol       Date:  2012-07-17       Impact factor: 6.280

3.  Real-time adaptive planning method for radiotherapy treatment delivery for prostate cancer patients, based on a library of plans accounting for possible anatomy configuration changes.

Authors:  Maria Antico; Peter Prinsen; Francesco Cellini; Alice Fracassi; Alfonso A Isola; David Cobben; Davide Fontanarosa
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

4.  Patient positioning variations to reduce dose to normal tissues during 3D conformal radiotherapy for high-risk prostate cancer.

Authors:  K Czigner; P Agoston; G Forgács; M Kásler
Journal:  Strahlenther Onkol       Date:  2012-05-23       Impact factor: 3.621

5.  Randomized clinical trial of postoperative strontium-90 radiation therapy for pterygia: treatment using 30 Gy/3 fractions vs. 40 Gy/4 fractions.

Authors:  Kiyoshi Nakamatsu; Yasumasa Nishimura; Shuichi Kanamori; Ryuta Koike; Izumi Tachibana; Tatsuyuki Nishikawa; Toru Shibata
Journal:  Strahlenther Onkol       Date:  2011-06-27       Impact factor: 3.621

6.  Quantitative imaging to assess tumor response to therapy: common themes of measurement, truth data, and error sources.

Authors:  Charles R Meyer; Samuel G Armato; Charles P Fenimore; Geoffrey McLennan; Luc M Bidaut; Daniel P Barboriak; Marios A Gavrielides; Edward F Jackson; Michael F McNitt-Gray; Paul E Kinahan; Nicholas Petrick; Binsheng Zhao
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

7.  Dosimetric comparison of image guidance by megavoltage computed tomography versus bone alignment for prostate cancer radiotherapy.

Authors:  Jörn Kalz; Florian Sterzing; Kai Schubert; Gabriele Sroka-Perez; Jürgen Debus; Klaus Herfarth
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

Review 8.  Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors.

Authors:  Prajwal Gurung; Thirumala-Devi Kanneganti
Journal:  Cell Mol Life Sci       Date:  2016-03-31       Impact factor: 9.261

9.  Original Knee Fixation Device as a Useful Fixation Method during Prostate Intensity-Modulated Radiation Therapy.

Authors:  Noriyuki Kuga; Katsutoshi Shirieda; Yuta Sato; Haruhiko Shimotabira; Yusuke Kurogi; Takashi Jinnouchi
Journal:  J Med Phys       Date:  2022-03-31

10.  Determining intrafractional prostate motion using four dimensional ultrasound system.

Authors:  Mariwan Baker; Claus F Behrens
Journal:  BMC Cancer       Date:  2016-07-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.